How NervGen is Developing Novel Treatments to Repair Damage to the Nervous System
Our guest for this podcast episode is Mike Kelly, President & CEO of NervGen Pharma. NervGen is a clinical-stage biotech company at the forefront of developing treatments that empower the nervous system to repair itself following damage from injury or disease.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.